BOD Australia Ltd (bod) Logo

BOD Australia Ltd (BOD)

___:___ · Healthcare
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

BOD Chart

Snapshot

BOD's Principal Activity is the development and manufacture of CBD and hemp products for consumer markets in Australia and United Kingdom as well as the development, manufacture and distribution of therapeutics medicinal cannabis products based on Good Manufacturing Practice (GMP) certified cannabis extracts for medical markets.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2021 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) -65.62%

Size

Market Capitalisation
ASX Rank 1,617 of 2,313
Sector Rank 148 of 203

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies OSX / LBT / IMC
EPS -$0.043
DPS $0.00
NTA per share $0.08

Broker Consensus

BOD is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Date Heading Pages File Size Time

Corporate Overview

Bod Australia Limited (BOD, formerly Bod Australia Limited) is a cannabis centric healthcare company.Delivering products for both the consumer markets and medical markets.

Incorporation Details

No incorporation details available.

Corporate Details

Head Office Double Bay NSW 2028
Website www.bodaustralia.com
Registry Link Market Services
Auditor Nexia Sydney Audit Pty Limited
Date Listed 27 Oct 2016

Upcoming Calendar (Forecasted)

Date Event
23/02/2022 Report (Prelim)
23/02/2022 Report (Annual)
24/02/2022 Report (Interim)
14/07/2022 Report (Quarterly)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors & Management

Name Title Since Bio
Mr Johannes (Hanno) Jacobus Cappon Non-Executive Director Jul 2021 Director Bio icon

Mr Johannes (Hanno) Jacobus Cappon

Non-Executive Director

Mr Cappon has experience in biochemistry, nutrition, health and innovation. He has a background in chemistry, life sciences, nutrition and health innovation and developing new consumer and healthcare solutions for commercialization. Mr Cappon is currently Chief Technology Officer at H&H, a position which he has held since January 2021. Mr Cappon's previous senior roles with international companies include VP R&D Nutritionals & Digestive Health at Bayer Consumer Health, Switzerland, as well as VP R&D Nutricia Medical Nutrition at multinational food company Danone Nutricia, Netherlands, amongst others.

Mr Mark Masterson Non-Executive Director,Non-Executive Chairman Nov 2019 Director Bio icon

Mr Mark Masterson

Non-Executive Director,Non-Executive Chairman

Mr Masterson has two decades of experience in the pharmaceutical and healthcare sectors. He began his career with Johnson & Johnson before joining Abbott Laboratories (NYSE: ABT) where he held senior positions. Mark also held the role of CEO with I-MED. Following the acquisition of I-MED, he was appointed Chairman of Medicines Australia.

Mr Akash Bedi Non-Executive Director Jul 2019 Director Bio icon

Mr Akash Bedi

Non-Executive Director

Mr Bedi is Group Senior Director of Strategy and Corporate Affairs at H&H Group. He is based in Hong Kong and is responsible for leading H&H Group's strategy and business development including mergers and acquisitions, and strategic investments for NewH2. He has experience in investing in global start-ups and companies with technologies and businesses that are of strategic importance to H&H Group. Akash has experience in multicultural and global environments. Prior to joining H&H Group, he was a Director of Global Consumer and Retail for HSBC for over a decade. During this time he worked on a number of acquisitions in North America, London and Asia. He is Director of Else Nutrition Holdings, Inc.

Mr Stephen Kelly Company Secretary Sep 2018
Mr George Livery Non-Executive Director Sep 2018 Director Bio icon

Mr George Livery

Non-Executive Director

Mr Livery has over 25 years' experience in senior roles domestically and internationally. His last seven years as director of strategy and corporate development at Swisse Wellness Group. In addition, George's executive experience is in positions across multiple other industries including the role of chief executive officer at Village Cinemas Australia, chief operating officer of Village International, commercial director at Hoyts Limited, and director of operations and marketing (non-academic services) at the University of Sydney. George is migration agent, not- for-profit advisor, corporate board strategist, investor and mentor.

Mr Simon Thomas O'Loughlin Non-Executive Director Oct 2016 Director Bio icon

Mr Simon Thomas O'Loughlin

Non-Executive Director

Mr O'Loughlin is the founder of O'Loughlins Lawyers. He has experience in the corporate and commercial law fields while practising in Sydney and Adelaide. Simon has experience and involvement with companies in the industrial and resources sectors. He is a former Chairman of the Taxation Institute of Australia (SA Division) and Save the Children Fund (SA Division). He is Director of Chesser Resources Limited, Petratherm Limited, Kibaran Resources Limited, Food Revolution Group Limited, Goldminex Limited, Oklo Resources Limited, Crest Minerals Limited, Reproductive Health Science Limited, King Solomon Mines Limited, Lawson Gold Limited, Gooroo Ventures Limited, ARC Exploration Limited and WCP Resources Limited.

Ms Joanne (Jo) Patterson Chief Executive Officer,Executive Director Oct 2016 Director Bio icon

Ms Joanne (Jo) Patterson

Chief Executive Officer,Executive Director

Ms Patterson has over 20 years' experience in business and corporate strategy in Australia and international markets. She has developed a number of businesses from start-up as well as driving established organisations towards growth and merger trajectories. Jo has held multiple CEO and Managing Director roles over her career.

Craig Weller Chief Operating Officer N/A

Director Interests

The current holdings of BOD directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Johannes (Hanno) Cappon 20/07/2021 0 N/A N/A N/A
Akash Bedi 23/12/2020 0 N/A 1,000,000 N/A
George Livery 16/10/2020 300,000 20,000 2,800,000 N/A
Mark Masterson 30/06/2020 N/A 441,176 750,000 N/A
Joanne (Jo) Patterson 30/06/2020 N/A 6,550,000 N/A N/A
Simon O'Loughlin 30/06/2020 N/A 1,160,000 500,000 N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Sep 18, 2020.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
New H2 Limited 14,864,865 16.27%
HSBC Custody Nominees (Australia) Limited 8,655,677 9.47%
Health And Beauty Enterprise Pty Limited 5,750,000 6.29%
Noir Ted Pty Ltd 4,852,329 5.31%
AWJ Family Pty Ltd 4,445,346 4.27%
J P Morgan Nominees Australia Pty Limited 3,319,960 3.63%
GP Securities Pty Ltd 2,143,572 2.35%
Citicorp Nominees Pty Limited 1,752,115 1.92%
Calama Holdings Pty Ltd 1,505,000 1.25%
Jimbzal Pty Ltd 1,360,000 1.27%
BNP Paribas Nominees Pty Ltd 1,115,300 1.22%
Yoix Pty Ltd 1,010,000 1.11%
Twenty Ten Enterprises Pty Ltd 960,277 1.05%
Ms Suzanne Taylor 897,671 0.98%
JGC Patterson Pty Ltd 800,000 0.88%
AWJ Family Pty Ltd (I) 716,084 0.78%
CS Third Nominees Pty Limited 620,100 0.68%
National Nominees Limited 582,218 0.64%
Bond Street Custodians Limited 441,176 0.48%
Baker Cook Advisory Pty Ltd 750 0.82%

Shareholder Distribution

As reported in the most recent Annual Report.

The most recent Annual Report didn't contain Shareholder Distribution data.

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Name Last Notice Total Shares Shares Held (%)
Noir Ted Pty Ltd 30/09/2020 4,852,329 5.31
Health and Happiness (H and H) Hong Kong Limited 30/09/2020 14,864,865 16.27
Health And Beauty Enterprise Pty Limited 30/09/2020 6,550,000 7.17
SG Hiscock & Company Limited 12/08/2021 10,201,728 9.64

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
12-08-21 SG Hiscock & Company Limited 2,341,520 8.60 9.64

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
No Financial Year End data available
Page Icon
BOD Historical Price Data (CSV)
Up to 20 years of EOD share price history
Lock Icon
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.